HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement.

AuthorsSilvana Capalbo, Antonia Chiefa, Mario Delia, Daniela Diomede, Vincenzo Liso
JournalActa oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 46 Issue 2 Pg. 262-4 ( 2007) ISSN: 0284-186X [Print] England
PMID17453381 (Publication Type: Case Reports, Letter)
Chemical References
  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Dexamethasone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bone Neoplasms (diagnostic imaging, drug therapy, secondary)
  • Boronic Acids (administration & dosage, therapeutic use)
  • Bortezomib
  • Dexamethasone (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Leukemia, Plasma Cell (diagnosis, drug therapy, pathology)
  • Middle Aged
  • Pyrazines (administration & dosage, therapeutic use)
  • Skull (diagnostic imaging)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: